GL1X · GenesisL1 explorer

Ligand · VAW

VAW · (2S,3R,4S)-methyl 4-(2-(2-(1H-indol-3-yl)ethylamino)ethyl)-2-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate

VAW, (2S,3R,4S)-methyl 4-(2-(2-(1H-indol-3-yl)ethylamino)ethyl)-2-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate (C27 H36 N2 O9, 532.6 g/mol), in the MolNFT…

Component
VAW
Formula
C27 H36 N2 O9
Class
ligand
Structures
2
PDB entries
1

Binding sites

VAW in 2 structures; the first of them:

  • 2VAQ · Structure of strictosidine synthase in complex with inhibitor · VAW A1334 · binds TRP149, TYR151, VAL167, VAL176, ILE179, MET180, VAL208, GLY210 and 9 more
  • 2VAQ · Structure of strictosidine synthase in complex with inhibitor · VAW A1334 · binds TRP149, TYR151, VAL167, VAL176, ILE179, MET180, VAL208, GLY210 and 9 more

Residues it binds most

VAL 4, GLU 4, GLY 4, HIS 4, MET 4, PHE 4, ILE 4, LEU 4, TRP 4, TYR 4 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.